Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026
Go back to Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026| (NASDAQ: DRMA) | Delayed: 1.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.16 | 52 Week High | $ | |||
| Open | $1.18 | 52 Week Low | $ | |||
| Day High | $1.19 | P/E | N/A | |||
| Day Low | $1.16 | EPS | $ | |||
| Volume | 3,408 | |||||

